Your monthly Mepsevii cost savings if eligible
With our assistance, you could access the Mepsevii patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Mepsevii patient assistance?
We review each Mepsevii enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Mepsevii patient assistance program?
Our process makes it as easy as possible to apply for the Mepsevii patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Mepsevii, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Mepsevii coupon provider?
NiceRx is not a Mepsevii coupon, Mepsevii discount card, or Mepsevii copay card provider. We do not offer Mepsevii manufacturer coupons, Mepsevii discounts, rebates, Mepsevii savings cards, trial
offers, or free Mepsevii samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me get Mepsevii cheaper if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Mepsevii
- Your insurance company will not pay for your Mepsevii prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Mepsevii cost without insurance?
Without insurance, Mepsevii costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Mepsevii intravenous solution (2 mg/mL) will cost around $2,550 for 5 milliliters.
How much does Mepsevii cost with insurance?
The copay for Mepsevii will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Mepsevii?
Mepsevii is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Ultragenyx Pharmaceutical Inc. It is a recombinant human lysosomal beta glucuronidase indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome).
MPS VII is a lysosomal storage disorder (LSD) caused by a deficiency of the beta-glucuronidase enzyme. Over time, the disease causes a buildup of glycosaminoglycans that can damage tissue and organs throughout the body. Mepsevii is an enzyme replacement therapy that works by replacing the missing enzyme.
Mepsevii is designated an ‘orphan medicine’ (a medicine used in rare diseases). The effect of Mepsevii on the central nervous system manifestations of MPS VII has not been determined.
What doses of Mepsevii are available?
Mepsevii is available in injection form, in the following doses: 10 mg/5 mL (2 mg/mL) in a single-dose vial.
For additional information on preparation, administration, and storage see the full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Mepsevii active ingredients
The active ingredient of Mepsevii is vestronidase alfa-vjbk.
Mepsevii side effects
The most common side effects of Mepsevii in clinical trials compared to placebo include:
- Infusion site extravasation
- Infusion site swelling
- Peripheral swelling
- Anaphylaxis can occur with the first dose, therefore appropriate medical support should be readily available when administered. Closely observe patients during and for 60 minutes after Mepsevii infusion. Immediately discontinue if the patient experiences anaphylaxis
Your doctor will assess the benefits of using Mepsevii against your risk of adverse effects. Patients are encouraged to report negative side effects or adverse reactions of Mepsevii to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Mepsevii drug interactions
Other drugs may interact with Mepsevii, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medicines including any supplements you are taking.
You should not use Mepsevii if you:
- Are allergic to the active ingredient vestronidase alfa-vjbk
- Have had a severe allergic reaction to any of the other ingredients in Mepsevii
- Are pregnant or are planning to become pregnant
Talk to your doctor before using Mepsevii if you:
- Are taking any of the medications that could interact with Mepsevii
- Are breastfeeding or are planning to breastfeed
Mepsevii is the trademark brand name for vestronidase alfa-vjbk manufactured by Ultragenyx Pharmaceutical Inc. A generic version of vestronidase alfa-vjbk is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Mepsevii savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.